Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
Francesco Paolo Cantatore,1 Nicola Maruotti,1 Addolorata Corrado,1 Domenico Ribatti2,3 1Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia, 2Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical S...
Enregistré dans:
Auteurs principaux: | Cantatore FP, Maruotti N, Corrado A, Ribatti D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/befd641cc2d2455daf343cfa3022d61f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease
par: Oksana Boyarchuk
Publié: (2020) -
Liver involvement in rheumatic diseases
par: Joanna Podgórska, et autres
Publié: (2020) -
COMPLEXITY OF EARLY DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES
par: M. V. Sklyanova, et autres
Publié: (2012) -
The challenge of screening for asymptomatic rheumatic heart disease in South Africa
par: Liesl Zühlke, et autres
Publié: (2017) -
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
par: Kalliopi Klavdianou, et autres
Publié: (2021)